Standard Automated Perimetry versus Matrix Frequency Doubling Technology Perimetry in Subjects with Ocular Hypertension and Healthy Control Subjects

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Lamparter, Julia ^a   Aliyeva, Shakhsanam ^a   Schulze, Andreas ^a   Berres, Manfred ^a,b   Pfeiffer, Norbert ^a   Hoffmann, Esther M ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES KOBLENZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR HYPERTENSION; MALE; MATRIX FREQUENCY DOUBLING TECHNOLOGY PERIMETRY; OBSERVATIONAL STUDY; OPTIC DISK; OUTCOME ASSESSMENT; PERIMETRY; PROSPECTIVE STUDY; RELIABILITY; STANDARD AUTOMATED PERIMETRY; STANDARDIZATION; SYNDROME DELINEATION; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT;

ADULT; AGED; ALGORITHMS; AUTOMATION; CASE-CONTROL STUDIES; COLOR; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; REFERENCE STANDARDS; VISUAL FIELD TESTS;

EID: 84874562371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057663     Document Type: Article

References (28)

1. Clement CI, Goldberg I, Healey PR, Graham S, (2009) Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma. Br J Ophthalmol 93: 582-588.
2. Kim TW, Zangwill LM, Bowd C, Sample PA, Shah N, et al. (2007) Retinal nerve fiber layer damage as assessed by optical coherence tomography in eyes with a visual field defect detected by frequency doubling technology perimetry but not by standard automated perimetry. Ophthalmology 114: 1053-1057.
3. Harwerth RS, Carter-Dawson L, Shen F, Smith EL, Crawford ML, (1999) Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci 40: 2242-2250.
4. Johnson CA, (1995) The Glenn A. Fry Award Lecture. Early losses of visual function in glaucoma. Optom Vis Sci 72: 359-370.
5. Spry PG, Johnson CA, Mansberger SL, Cioffi GA, (2005) Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma 14: 11-19.
6. Zarkovic A, Mora J, McKelvie J, Gamble G, (2007) Relationship between second-generation frequency doubling technology and standard automated perimetry in patients with glaucoma. Clin Experiment Ophthalmol 35: 808-811.
7. Spry PG, Hussin HM, Sparrow JM, (2005) Clinical evaluation of frequency doubling technology perimetry using the Humphrey Matrix 24-2 threshold strategy. Br J Ophthalmol 89: 1031-1035.
8. Johnson CA, Cioffi GA, Van Buskirk EM, (1999) Frequency doubling technology perimetry using a 24-2 stimulus presentation pattern. Optom Vis Sci 76: 571-581.
9. Bozkurt B, Yilmaz PT, Irkec M, (2008) Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients. J Glaucoma 17: 203-210.
10. Artes PH, Hutchison DM, Nicolela MT, LeBlanc RP, Chauhan BC, (2005) Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma. Invest Ophthalmol Vis Sci 46: 2451-2457.
11. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, et al. (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120: 714-720; discussion 829-730.
12. Quigley HA, (1998) Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology. Am J Ophthalmol 125: 819-829.
13. Sample PA, Bosworth CF, Blumenthal EZ, Girkin C, Weinreb RN, (2000) Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci 41: 1783-1790.
14. Johnson CA, Samuels SJ, (1997) Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci 38: 413-425.
15. Medeiros FA, Sample PA, Weinreb RN, (2004) Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol 137: 863-871.
16. Cello KE, Nelson-Quigg JM, Johnson CA, (2000) Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol 129: 314-322.
17. Spry PG, Johnson CA, (2002) Within-test variability of frequency-doubling perimetry using a 24-2 test pattern. J Glaucoma 11: 315-320.
18. Spry PG, Johnson CA, McKendrick AM, Turpin A, (2001) Variability components of standard automated perimetry and frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci 42: 1404-1410.
19. Leeprechanon N, Giangiacomo A, Fontana H, Hoffman D, Caprioli J, (2007) Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma. Am J Ophthalmol 143: 263-271.
20. Nakagawa S, Murata H, Saito H, Nakahara H, Mataki N, et al. (2012) Frequency doubling technology for earlier detection of functional damage in standard automated perimetry-normal hemifield in glaucoma with low-to-normal pressure. J Glaucoma 21: 22-26.
21. Nakagawa S, (2004) A farewell to Bonferroni: the problems of low statistical power and publication bias. Behavioral Ecology 15 (6): 1044.1045.
22. Bland JM, Altman DG, (1995) Multiple significance tests: the Bonferroni method. BMJ 310: 170.
23. Perneger TV, (1998) What's wrong with Bonferroni adjustments. BMJ 316: 1236-1238.
24. Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA, (2000) Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology 107: 1809-1815.
25. Fukushima A, Shirakashi M, Yaoeda K, Funaki S, Funaki H, et al. (2004) Relationship between indices of Humphrey perimetry and Frequency Doubling Technology Perimetry in glaucoma. J Glaucoma 13: 114-119.
26. Weinreb RN, Kaufman PL, (2011) Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function. Invest Ophthalmol Vis Sci 52: 7842-7851.
27. Cellini M, Toschi PG, Strobbe E, Balducci N, Campos EC, (2012) Frequency doubling technology, optical coherence technology and pattern electroretinogram in ocular hypertension. BMC Ophthalmol 12: 33.
28. Lamparter J, Russell RA, Schulze A, Schuff AC, Pfeiffer N,et al. (2012) Structure-Function Relationship between FDF, FDT, SAP, and Scanning Laser Ophthalmoscopy in Glaucoma Patients. Invest Ophthalmol Vis Sci 53: 7553-7559.